SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group operates 15 manufacturing sites and 5 R&D centers in Europe, North America and Asia. 2,700 employees contribute to the success of SEQENS, among which 300 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.
Looking for a particular SEQENS employee's phone or email?
The SEQENS annual revenue was $1.1 billion in 2026.
Ludovic Lyonnet is the Managing Director of SEQENS.
1,118 people are employed at SEQENS.
SEQENS is based in Écully, Auvergne-Rhône-Alpes.